longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Ping An Biomedical

PASW

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -31.36, below the reasonable range, cheaper than 98.82% of the time in the past 1 years, and the industry ranks 21/25, the industry Median 5.57.

-31.36xP/E
$0.13Stock price
$-0.00Earnings per share
-31.36xP/E
Stock price$0.13Earnings per share$-0.00

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-10.66x
Typical range
-14.83x–-3.02x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 5.57x
0134268402536

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 5.57x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
PLBLUSPolibeli
-1,198.81x--$2.33B
BRIAUSBrillia
-2,593.94x--$44.10M
SMJFUSSMJ
-41.90x--$30.20M
EPSMUSEpsium Enterprise
-11.22x--$16.80M
PASWUSPing An Biomedical
-31.36x--$16.78M
RCTUSRedcloud
-0.29x97.09%$13.47M
INEOUSINNEOVA
-21.71x--$8.62M
AIXNUSAiXin Life International, Inc.
-3.18x--$6.50M
JEMUS707
-0.17x--$2.67M
GNLNUSGreenlane
-0.01x--$1.72M
FVTIUSFortune Valley Treasures, Inc.
----$981.57K
KAVLUSKaival Brands Innovations
-0.05x--$586.06K

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.